气候变化对喘和过敏免疫性疾病的影响
Grace Kelly1, Osatohamwen I Idubor2, Sophie Binney2,3
1Epidemiology Elective Program, National Center for STLT Public Health Infrastructure and Workforce, and Asthma and Community Health Branch, Division of Environmental Health Science and Practice, National Center for Environmental Health, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Current allergy and asthma reports
|June 7, 2023
概括
气候变化加剧了喘和过敏性疾病,增加了对触发因素的暴露,并扰乱了护理. 公共卫生战略和医疗保健资源可以帮助减轻这些对气候敏感的健康影响.
科学领域:
- 环境健康 环境健康
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
背景情况:
- 气候变化对人类健康构成多方面的威胁,特别是影响呼吸系统和免疫系统.
- 喘和过敏免疫性疾病越来越容易受到气候变化带来的环境变化的影响.
研究的目的:
- 审查气候变化对喘和过敏免疫性疾病的影响.
- 讨论当前的美国公共卫生倡议,解决这些气候敏感条件.
- 突出了医疗保健专业人员管理受影响患者群体的可用资源.
主要方法:
- 文献综述综合了当前关于气候变化对过敏和免疫疾病影响的研究.
- 对卫生保健中气候变化适应的公共卫生战略和框架的分析.
- 对医疗保健提供者和患者的资源的识别和分类.
主要成果:
- 气候变化通过增加对空气过敏原和臭氧等触发物的暴露,加剧了喘和过敏性疾病.
- 与气候有关的灾害破坏了医疗保健的获取,使疾病管理复杂化,并不成比例地影响弱势社区.
- 现有的公共卫生框架和专业资源旨在追踪,预防和应对气候敏感的健康威胁.
结论:
- 气候变化对患有喘和过敏免疫性疾病的个人构成重大风险,可能会加剧健康差异.
- 积极的公共卫生努力和目标资源的利用对于减轻气候相关的不良健康结果至关重要.
- 医疗保健专业人员在教育和支持患者预防气候变化相关健康影响方面发挥着关键作用.
相关概念视频
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma: Pathogenesis and Management
462
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
462
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
358
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
358
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K


